Financing the delivery of vaccines to children and adolescents: challenges to the current system

Pediatrics
Megan C LindleyGuthrie S Birkhead

Abstract

Recent increases in the number and costs of vaccines routinely recommended for children and adolescents have raised concerns about the ability of the current vaccine financing and delivery systems to maintain access to recommended vaccines without financial barriers. Here we review the current state of US financing for vaccine delivery to children and adolescents and identify challenges that should be addressed to ensure future access to routinely recommended vaccines without financial barriers. Challenges were considered from the perspectives of vaccine providers; state and local governments; insurers, employers, and other health care purchasers; vaccine manufacturers; and consumers.

References

Dec 31, 1997·Archives of Pediatrics & Adolescent Medicine·G FairbrotherG C Butts
Jul 13, 1999·Archives of Pediatrics & Adolescent Medicine·G L FreedJ Serling
Sep 18, 1999·American Journal of Preventive Medicine·G Solanki, H H Schauffler
May 2, 2000·American Journal of Preventive Medicine·P G SzilagyiL E Rodewald
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alan R HinmanLance Rodewald
Apr 7, 2005·Health Affairs·Todd Gilmer, Richard Kronick
May 12, 2005·Health Affairs·Walter A OrensteinAlan R Hinman
Dec 7, 2005·Archives of Pediatrics & Adolescent Medicine·Fangjun ZhouRafael Harpaz
Jan 21, 2006·American Journal of Health Promotion : AJHP·Maris Ann BondiBeth Umland
Feb 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jerome O Klein, Martin G Myers
Mar 7, 2007·Archives of Pediatrics & Adolescent Medicine·Cynthia M RandPeter G Szilagyi
Aug 9, 2007·JAMA : the Journal of the American Medical Association·Grace M LeeTracy A Lieu
Nov 3, 2007·Pediatrics·Noëlle-Angélique M MolinariRichard A Schieber
Nov 15, 2007·JAMA : the Journal of the American Medical Association·Sandra W RoushUNKNOWN Vaccine-Preventable Disease Table Working Group
Mar 18, 2008·Lancet·Jon S AbramsonStanley A Gall
May 1, 2008·Expert Review of Vaccines·Anne Schuchat, Beth P Bell
Jul 12, 2008·American Journal of Preventive Medicine·UNKNOWN National Vaccine Advisory Committee
Dec 3, 2008·Pediatrics·Gary L FreedSarah J Clark
Dec 3, 2008·Pediatrics·UNKNOWN Committee on Coding and Nomenclature
Jan 9, 2010·Pediatrics·Margaret S ColemanLance Rodewald
Jan 9, 2010·Pediatrics·Judith E GlaznerStephen Berman
Jan 9, 2010·Pediatrics·Byung-Kwang YooMargaret S Coleman
Jan 9, 2010·Pediatrics·Philip J SmithLance E Rodewald
Jan 9, 2010·Pediatrics·Philip J SmithLance E Rodewald
Jan 9, 2010·Pediatrics·UNKNOWN National Vaccine Advisory Committee

❮ Previous
Next ❯

Citations

Nov 10, 2010·Annals of Family Medicine·Doug Campos-OutcaltHerbert F Young
Dec 15, 2010·Current Opinion in Pediatrics·Robert A Bednarczyk, Guthrie S Birkhead
Nov 30, 2012·The Pediatric Infectious Disease Journal·Kosuke KawaiBarbara J Kuter
Aug 9, 2011·Expert Review of Anti-infective Therapy·Julia M L Brotherton, Dorota M Gertig
Feb 6, 2016·American Journal of Preventive Medicine·Verughese JacobUNKNOWN Community Preventive Services Task Force
Dec 17, 2011·Trends in Molecular Medicine·Su M Metcalfe, Tarek M Fahmy
Jan 17, 2012·Academic Pediatrics·Cynthia M Rand, Sharon G Humiston
Jun 15, 2011·Lancet·Orin S LevineBrian Greenwood
Aug 14, 2010·Pediatric Annals·Russell C Libby, Richard H Schwartz
Jul 8, 2015·The Journal of School Health·Judith C ShlayEmily V McCormick
Sep 1, 2015·Pediatric Clinics of North America·Svapna S Sabnis, James H Conway
Aug 3, 2012·Human Vaccines & Immunotherapeutics·Steven H WeinbergMatthew M Davis
Jan 10, 2012·Vaccine·Charitha Gowda, Amanda F Dempsey
May 5, 2016·Human Vaccines & Immunotherapeutics·Tricia WashburnAnneMarie Beardsworth
Jul 20, 2016·CA: a Cancer Journal for Clinicians·Debbie SaslowUNKNOWN American Cancer Society Guideline Development Group
May 3, 2014·Health Education & Behavior : the Official Publication of the Society for Public Health Education·Shelley D GoldenNoel T Brewer
Feb 10, 2016·Health Affairs·David B RidleyEli B Liebman
Jun 28, 2018·Qualitative Health Research·Salini MohantyAlison M Buttenheim
Jun 19, 2013·Maternal and Child Health Journal·Amber M GoedkenLinnea A Polgreen
May 11, 2011·Public Health Reports·Emily F ShortridgeAngela K Shen
Dec 2, 2014·Expert Review of Vaccines·Matthew J Robbins, Sheldon H Jacobson
Oct 3, 2018·Journal of Public Health Management and Practice : JPHMP·Suchita A PatelRobert Moore
Apr 14, 2019·International Journal of Health Policy and Management·Pascale LehouxRéjean Hébert
Mar 10, 2016·Public Health Reports·J Mac McCullough
Dec 4, 2019·Policy, Politics & Nursing Practice·Christy PowellKim Curry
Jun 22, 2019·Preventive Medicine Reports·Yuping TsaiShannon Stokley
Jan 9, 2010·Pediatrics·Philip J SmithLance E Rodewald
Jan 9, 2010·Pediatrics·UNKNOWN National Vaccine Advisory Committee
Jun 2, 2010·Pediatrics·Lawrence D HammerUNKNOWN Council on Community Pediatrics
Feb 26, 2014·Pediatrics·Sean T O'LearyAllison Kempe
Oct 3, 2012·Pediatrics·Emily V McCormickJudith Shlay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.